Chapter 30: Acute Coronary Syndromes Flashcards
An acute coronary syndrome results from ____ buildup in the _____ (coronary atherosclerosis).
plaque
coronary arteries
Plaque buildup can rupture, leading to ____ formation and _____ to the heart.
thrombus
ischemia
Risk factors that lead to plaque buildup that causes an ACS
- Age: men > 45 years, women > 55 years (or early hysterectomy
- Family hx: 1st degree relative w/ coronary event before 55 years (men) or 65 years (women)
- Smoking
- HTN
- Known coronary artery disease
- Dyslipidemia
- Diabetes
- Chronic angina
- Lack of exercise
- Excessive alcohol
Classic signs and symptoms of ACS
chest pain (pressure and squeezing) lasting > 10 min, severe dyspnea, diaphoresis, syncope/presyncope, and/or palpitations
Pain from ACS can radiate to
arms, back, neck, jaw, or epigastric region
Patients with a prescription for SL nitroglycerin should use __ dose(s) every __ min up to ___ doses for relief of chest pain. If the pain is not improved or is worse __ min after the first dose, call 911 immediately
one dose every 5 min up to 3 doses
5 min
NSTE-ACS describes which 2 medical conditions
Unstable angina & NSTEMI
Cardiac enzymes in unstable angina are (neg/pos)
Cardiac enzymes in NSTEMI are (neg/pos)
Cardiac enzymes in STEMI are (neg/pos)
UA - negative
NSTEMI - Positive
STEMI - Positive
There is (partial/complete) blockage in unstable angina There is (partial/complete) blockage in NSTEMI There is (partial/complete) blockage in STEMI
UA - partial
NSTEMI - partial
STEMI - complete
___ should be performed and evaluated within 10 minutes at the site of first medical contact after ACS
A 12-lead ECG
Patients with STEMI or NSTEMI should be urgently transported to a hospital with _____ capability, if possible
percutaneous coronary intervention (PCI)
What are the most sensitive and specific biomarkers for ACS
Cardiac troponins I & T (TnI and TnT)
When should cardiac troponin levels be obtained in all patients with ACS symptoms
At presentation & 3-6 hours after symptom onset
What is PCI
a coronary revascularization procedure that involves inflating a small balloon inside a coronary artery to widen it and improve blood flow. Usually, a metal stent is placed into the artery after to keep it open
In STEMI, the blocked arteries need to be opened how quickly
as quickly as possible with PCI (preferred) or fibrinolytics
Acute treatment of ACS is aimed at
Immediate relief of ischemia & preventing MI expansion and death
Drug treatment for ACS
- remember MONA-GAP-BA*
- Morphine
- Oxygen
- Nitrates
- Aspirin
- GPIIb/IIIa antagonists
- Anticoagulants
- P2Y12 inhibitors
- Beta-blockers
- ACE inhibitors
Which antianginals are used in ACS
Morphine, BB, nitrates
MOA of antianginals in ACS
Decrease myocardial O2 demand or increase myocardial O2 supply (blood flow) to relieve ischemia
MOA of antiplatelets in ACS
Inhibit platelet aggregation to prevent clot formation/growth
MOA of anticoagulants in ACS
inhibit clotting factors to prevent clot formation/growth
NSTE-ACS (i.e, NSTEMI and unstable angina) are treated with:
MONA-GAP-BA +/- PCI
STEMI is treated with
MONA-GAP-BA + PCI (preferred) or fibrinolytic
When should morphine, O2, nitrates and ASA (MONA) be given
Immediately as needed
MOA of morphine in ACS
Antianginal; produces arterial and venous dilation (↓ preload and afterload)
Provides pain relief
MOA of nitrates in ACS
Antianginal: dilates coronary arteries and improves collateral blood flow; ↓ preload and afterload (modestly); reduces chest pain
Which dose and formulation of NTG should be administered in ACS
SL 0.4 mg
Which drug class is CI with nitrates
PDE5-i
Which dose and formulation of aspirin should be administered in ACS
Non-EC, chewable ASA
162-325 mg
Do not use which formulation of ASA in ACS
extended release
What is the maintenance dose of ASA that should be continued indefinitely in ACS
81-162 mg daily
Which drugs are GPIIb/IIIa receptor antagonists
abciximab, eptifibatide, and tirofiban
Which anticoagulant is preferred for STEMI
bivalirudin
Which anticoagulants are used in ACS
LMWHs (e.g. enoxaparin, dalteparin), UFH and bivalirudin
Which P2Y12 inhibitors are used in ACS
clopidogrel, prasugrel, and ticagrelor
Which drugs are given within 24 hrs (as needed) in ACS & continued as outpatient
BB and ACEi
Why are BB used in ACS
they increase long-term survival
Which type of BB is preferred in ACS
oral low dose BB (B1 selective blocker without intrinsic sympathomimetic activity preferred)
Which BB do have ISA & should be avoided post-MI
Acebutolol, penbutolol and pindolol
Which two drugs are continued indefinitely post ACS
BB & ACEi (in pts with LVEF < 40%, HTN, DM, or stable CKD)
Which medications should be avoided in ACS
- NSAIDs (except ASA) should not be administered during hospitalization
- IR nifedipine d/t increased risk of mortality
MOA of aspirin
inhibits platelet aggregation/clot formation by inhibiting production of TXA2 via irreversible COX1 and COX2 inhibition
MOA of P2Y12 inhibitors
bind to the ADP P2Y12 receptor on the platelet surface which prevents ADP-mediated activation of the GPIIb/IIIa receptor complex, thereby reducing platelet aggregation
GPIIb/IIIa receptor antagonists MOA
block the platelet glycoprotein IIb/IIIa receptor, which is the binding site for fibrinogen, vWf and other ligands, thereby ↓ plt aggregation and further thrombosis
Vorapaxar MOA
PAR-1 antagonist that reversibly binds to the PAR-1 expressed on platelets, preventing thrombin-induced and thrombin receptor agonist peptide-induced platelet aggregation
Which two P2Y12 inhibitors are prodrugs that irreversibly bind to the receptor
Clopidogrel and prasugrel
Clopidogrel and prasugrel are classified as
thienopyridines
P2Y12 inhibitors are commonly used with ___ after ACS
Aspirin
Clopidogrel maintenance dose
75 mg PO daily
note: a much higher loading dose is required either prior to PIC or at the time of dx if PCI is not performed
Clopidogrel effectiveness depends on the conversion to _____, mainly by which CYP enzyme?
an active metabolite
2C19
Clopidogrel CI
active serious bleeding
Clopidogrel should be stopped ___ days prior to elective surgery
5
Do not use clopidogrel with these 2 drugs d/t severe drug interaction
Omeprazole and esomeprazole
All P2Y12 inhibitors can cause
Thrombotic thrombocytopenic purpura (TTP)
Prasugrel brand name
Effient
Which P2Y12 inhibitor must be dispensed in its original container to protect from moisture
Prasugrel
Ticagrelor brand name
Brillinta
Which P2Y12 inhibitor comes as an injection
Cangrelor
Ticagrelor maintenance dose
90 mg PO BID for 1 year, then 60 mg BID
Prasugrel CI
Active serious bleeding, history of TIA or stroke
Prasugrel should be stopped ___ days prior to elective surgery
7
If using Ticagrelor, after the initial dose of 162-325 mg of ASA, do not exceed aspirin ___ mg for maintenance doses because higher daily doses can reduce the effectiveness of ticagrelor
100 mg
Ticagrelor should be stopped ___ days prior to any surgery
5
Besides bleeding, what is another side effect of ticagrelor
Dyspnea
think of a tiger chasing you and you’re out of breath
Which drugs can increase the risk of bleeding and should be avoided with P2Y12 inhibitors
NSAIDs, SSRI, SNRI, and warfarin
Abciximab brand name
ReoPro (a pro with abs)
Eptifibatide brand name
Integrilin
Side effect of GPIIb/IIIa receptor antagonists
Bleeding, thrombocytopenia
MOA of fibrinolytics
cause fibrinolysis (clot breakdown) by binding to fibrin and converting plasminogen to plasmin
Fibrinolytics are only used for
STEMI
PCI for STEMI is preferred if it can be performed within __ minutes (optimal door-to-balloon time) or within __ minutes of first medical contact (which could be in an ambulance)
90
120
If PCI is not possible, fibrinolytic therapy is recommended for STEMI and should be given within __ min of hospital arrival (door-to-needle time)
30
Which drugs are fibrinolytics
Alteplase (tPA) and tenecteplase
Alteplase brand name
Activase Cathflo Activase (single-use 2 mg vial)
tenecteplase brand name
TNKase
Fibrinolytic CI
Active internal bleeding
history of recent stroke
severe uncontrolled HTN
Alteplase CI and dosing differ for which condition
ischemic stroke
Drugs used for secondary prevention after ACS & duration
- Aspirin 81 mg/day indefinitely
- P2Y12 inhibitor
- NTG indefinitely
- BB: 3 years; indefinitely if HF or if needed for HTN
- ACEi indefinitely if EF < 40%, HTN, CKD or diabetes
- Aldosterone antagonist if EF = 40% and either sx HF or DM receiving target doses of an ACEi and BB
- High-intensity Statin indefinitely
Aldosterone antagonist CI
significant renal impairment (SCr > 2.5 mg/dl in men, SCr > 2 mg/dl in women) or hyperkalemia (K > 5 mEq/L)
Which P2Y12 inhibitors can a patient who was treated with PCI receive (including any type of stent) for secondary prevention after ACS
Clopidogrel, prasugrel or ticagrelor with ASA 81 mg for at least 12 months
Continuation of dual antiplatelet therapy beyond 12 months can be considered in pts who received a PCI or stent in which pts
Pts who are tolerating DAPT and are not at high risk of bleeding following coronary stent placement
Which P2Y12 inhibitors can a patient who received fibrinolytics receive for secondary prevention after ACS
Ticagrelor or clopidogrel with ASA 81 mg for at least 12 months
Which NSAID can be used for pain relief after ACS
Naproxen (lowest CV risk)
Which NSAIDs should be avoided after ACS since they have high CV risk
COX-2 selective NSAIDs (Bextra, Celebrex, and Vioxx)
Which drug class should be prescribed in any patient with a history of GI bleeding while taking triple antithrombotic therapy
PPIs